LCGC E-Books July 2017

July 2017 | Volume e5, Issue 7

Analyzing Genotoxic Impurities in Pharmaceuticals

Detecting and preventing the introduction of genotoxic impurities (GIs) into drug substances is a top-of-mind concern for pharmaceutical companies. GI analysis is not easy, however, because it often requires methods that offer excellent selectivity and sensitivity at sub-part-per-million levels. How can new analytical methods help improve and accelerate GI detection and analysis?
Click the title below to open this issue
lorem ipsum